Moreover, diAcCA may prove useful not just for AD, but potentially for other neurodegenerative disorders and systemic maladies in which activation of the Nrf2 transcriptional pathway to alleviate inflammation and oxidative stress should modify disease pathogenesis [62,63,64,65,66]. This evidence concerns the gene NFE2L2 and Alzheimer disease.